ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999